Hill Publishing Group | contact@hillpublisher.com

Hill Publishing Group

Location:Home / Journals / International Journal of Clinical and Experimental Medicine Research /


Advances in Research on the Incidence, Risk and Treatment of Crohn’s Disease during Pregnancy

Date: January 11,2022 |Hits: 174 Download PDF How to cite this paper

Yan Ou1, Yaping Cui2,*, Qiangqiang Gao2, Lu Lin2, Jiyun Wu1, Yanrong Zhan1

1First Clinical Medical School, Shaanxi University of Chinese Medicine, Century Avenue, Xi’an, 710000, Shaanxi, China. 

2Affiliated Hospital of Shaanxi University of Chinese Medicine, Weiyang West Road, Xianyang, 712000, Shaanxi, China.

*Corresponding author: Yaping Cui


Crohn’s disease is an intestinal inflammatory disease of unknown cause, which is clinically divided into acute phase, subacute phase, and chronic phase. The disease symptoms can invade the entire digestive tract, and the most typical lesions are concentrated at the end of the ileum and its adjacent colon. The main manifestations of patients are diarrhea, abdominal pain, fistulas and perforating inflammation, most of which are in segmental and asymmetrical distribution. The symptoms are characterized by repeated attacks and alternating relief. There is no treatment plan to completely cure Crohn’s disease. During pregnancy, the various systems of women’s bodies have undergone tremendous changes due to the gestation of the fetus, so various complications are prone to occur, which is an important critical period for women of childbearing age. In addition, there are many contraindications to medication during pregnancy, so the treatment of ulcerative colitis during pregnancy has become a difficult problem. Therefore, urgent research for understanding the incidence, risk and treatment of Crohn’s disease during pregnancy based on the existing evidence in practice diagnosis and treatment as well as the pregnancy safety information of relevant therapeutic drugs is required. Such research will help us accurately evaluate the corresponding diagnosis and treatment methods during pregnancy. Moreover, it can provide the best advice and management for patients with Crohn’s disease who are pregnant and planning to become pregnant.


[1] Zheng, J. J., Shi, X. H., Zhu, X. H., et al. (2011). Comparison of the incidence and prevalence of Crohn’s disease in different years in China [J]. Journal of General Internal Medicine, 2011, 50: 597-600.

[2] Deng, C. S. and Qi, Y. H. (2008). Special problems of inflammatory bowel disease [J]. Journal of Clinical Internal Medicine, 2008, 25(2): 88.

[3] Cornish, J., Tan, E., Teare, J., et al. (2007). A meta-analysis on influence of inflammatory bowel disease on pregnancy [J]. Gut, 2007, 56: 830-837.

[4] Habal, F. M. and Huang, V. W. (2012). Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient [J]. Aliment Pharmacol Ther, 2012, 35(5): 501-515.

[5] Pedersen, N. and Bortoli, A., et al. (2013). The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women [J]. Aliment Pharmacol Ther, 2013, 38: 501-512. 

[6] Abhyankar, A., Ham, M., Moss, A. C. (2013). Commentary: impact of disease activity at conception on disease activity during pregnancy in patients with inflammation bowel disease-authors’ reply [J]. Aliment Pharmacol Ther, 2013, 38: 843.

[7] Khosla, R., Willoughby, C. P., Jewell, D. P. (1984). Crohn’s disease and pregnancy [J]. Gut, 1984, 25: 52-56.

[8] Cornish, J., Tan, E., Teare, J., et a1. (2007). A meta-analysis on the influence of inflammatory bowel disease on pregnancy [J]. GUT, 2007, 56(6): 830-837.

[9] Kane, S., Kisiel, J., Shih, L., et al. (2004). HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease [J]. Am J Gastroenterol, 2004, 99: 1523-1526.

[10] Mittermaier, C., Dejaco, C., Waldhoer, T., et a1. (2004). Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study [J]. Psychosom Med, 2004, 66(1): 79-84. 

[11] Lu, J., Wu, J. X. (2008). The relationship between inflammatory bowel disease and pregnancy [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2008, 3(28): 218. 

[12] Wu, X. N. Crohn’s disease [A], See: Shudong Xiao, Shaoji Jiang. (2001). Gastroenterology [M]. Shanghai Science and Technology Publishing House, 2001. 413. 

[13] Sandborn, W. J. (2012). The future of inflammatory bowel disease therapy: where do go from here [J]. Dig Dis, 2012, 30(suppl 3): 140-144. 

[14] Seung, H. B. and Won, H. K. (2012). A comprehensive review of inflammatory bowel disease focusing on surgical management [J]. J Korean Soc Coloproctol, 2012, 28(3): 121-131. 

[15] Ooi, C. J., Makharia, G. K., Hilmi, I., et al. (2016). Asia-Pacific consensus statements on Crohn’s disease [J]. J Gastroenterol Hepatol, 2016, 31(1): 56-58.

[16] Spinelli, A., Sacchi, M., Fiorino, G. (2011). Risk of postoperative recurrence and postoperative management of Crohn’s disease [J]. World J Gastroenterol, 2011, 17(27): 3213-3219. 

[17] Zallot, C. L. and Peyrin, B. (2013). Clinical risk factors for complicated disease: how reliable are they [J]. Dig Dis, 2013, 30 (suppl 3): 62-72.

[18] Rutgeerts, P., Geboes, K., Vantrappen, G., et a1. (1990). Predictability of the postoperative course of Crohn’s disease [J]. Gas-troenterology, 1990, 99(4): 956-963.

[19] Wu, K. C., Liang, J., Ran, Z. H., et al. (2018). Consensus opinions on the diagnosis and treatment of inflammatory bowel disease [J]. Chinese Journal of Practical Internal Medicine, 2018, 38(9): 796-813.

[20] Shen, R. T., Li, P., et al. (2015). Nursing care of a case of Crohn’s disease undergoing family enteral nutrition support treatment during pregnancy [J]. Journal of General Surgery for Clinicians (Electronic Version), 2015, 3(3): 65-67.

[21] Huang, Y. C., Wang, X. Y., Peng, N. H. (2011). Analysis on the results of telephone follow-up of family enteral nutrition [J]. Journal of Parenteral and Enteral Nutrition, 2011, 18(2): 125-126.

[22] Van Assche G., Dignass A., Reinisch W., et al. (2010). The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Special situations [J]. J Crohns Colitis, 2010, 4(1): 63-101.

[23] Beaulieu, D. B., Kane, S. (2011). Inflammatory bowel disease in pregnancy [J]. World J Gastroenterol, 2011, 17(22): 2696-2701.

[24] Dignass, A., Van Assche, G., Lindsay, J. O., et al. (2010). The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Current management [J]. J Crohns Colitis, 2010, 4(1): 28-62.

[25] Blatt, J., Mulvihill, J. J., Ziesler, J. L., et a1. (1980). Pregnancy outcome following cancer chemotherapy [J]. Am J Med, 1980, 69(6): 828-832.

[26] Francella, A., Dyan, A., Bodian, C., et a1. (2003). The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study [J]. Gastroenterology, 2003, 124.

[27] Dejaco, C., Angelberger, S., Waldhoer, T., et a1. (2005). Pregnancy and birth outcome under thiopurine therapy for inflammatory bowel disease [J]. Gastroenterology, 2005, 128(suppl 2), A12.

[28] Li, D., Pan, X. J., He, J. (2011). A Randomized Controlled Study of Bifidus Sanlian Huojun Tablets and Montmorillonite Powder in Treating Diarrhea of Pregnancy [J]. Sichuan Medical Journal, 2011, 32: 506-507.

[29] Riis, L., Vind, I., Politi, P., et al. (2006). Dose pregnancy change the disease course: A study in European cohort of patients with inflammatory bowel disease [J]. Am J Gastroenterol, 2006, 101: 1539-1545.

[30] Hatch, Q., Champagne, B. J., Maykel, J. A., et al. (2014). Crohn’s disease and pregnancy: the impact of perianal disease on delivery methods and complications [J]. Dis Colon Rectum, 2014, 57: 174-178.

[31] Nguyen, G. C., Seow, C. H., Maxwell, C., et al. (2016). The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy [J]. Gastroenterology, 2016, 150(3): 734-757. 

[32] Moffatt, D. C., Ilnyckyj, A., Bernstein, C. N. (2009). A population-based study of breastfeeding in inflammatory bowel disease: initiation, duration, and effect on disease in the post-partum period [J]. Am J Gastroenterol, 2009, 104(10): 2517-2523.

[33] Barclay, A. R., Russell, R. K., Wilson, M. L., et al. (2009). Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease [J]. J Pediatr, 2009, 155(3): 421-426.

[34] Fu, G. L. (2015). Evaluation and treatment of mental illness during pregnancy [J]. Guide of China Medicine, 2015, 13(31): 286.

[35] Bush, M. C., Patel, S., Lapinski, R. H., et al. (2004). Perinatal outcomes in inflammatory bowel disease [J]. J Matern Fetal Neonatal Med, 2004, 15: 237-241.

How to cite this paper

Advances in Research on the Incidence, Risk and Treatment of Crohn’s Disease during Pregnancy

How to cite this paper: Yan Ou, Yaping Cui, Qiangqiang Gao, Lu Lin, Jiyun Wu, Yanrong Zhan. (2022) Advances in Research on the Incidence, Risk and Treatment of Crohn’s Disease during PregnancyInternational Journal of Clinical and Experimental Medicine Research6(1), 68-73.

DOI: http://dx.doi.org/10.26855/ijcemr.2022.01.012

Volumes & Issues

Free HPG Newsletters

Add your e-mail address to receive free newsletters from Hill Publishing Group.

Contact us

Hill Publishing Group

8825 53rd Ave

Elmhurst, NY 11373, USA

E-mail: contact@hillpublisher.com

Copyright © 2019 Hill Publishing Group Inc. All Rights Reserved.